Table 4.
Affordability analysis by condition type*
| Condition Type | Treatment Example | Public Sector (Days’ Wages) | Private Sector (Days’ Wages) | Private: Public Ratio |
|---|---|---|---|---|
| Acute | Antibiotics (Amoxicillin) | 0.4 (0.2–0.7) | 2.1 (1.5–3.2) | 5.3:1 |
| Antimalarials (ACT) | 0.3 (0.1–0.6) | 1.7 (1.1–2.6) | 5.7:1 | |
| Analgesics (Paracetamol) | 0.1 (0.05–0.3) | 0.8 (0.5–1.4) | 8.0:1 | |
| Chronic | Hypertension (Amlodipine) | 1.3 (0.8–2.0) | 4.3 (2.9–6.2) | 3.3:1 |
| Diabetes (Metformin) | 1.9 (1.3–2.8) | 5.9 (4.0–8.3) | 3.1:1 | |
| Mental Health (Amitriptyline) | 2.5 (1.7–3.6) | 7.4 (5.0–10.3) | 3.0:1 | |
| Combination Therapy | 3.9 (2.6–5.5) | 9.0 (6.2–12.5) | 2.3:1 |
•Table 4 Affordability analysis by condition type
•Days' wages required for different treatments in public and private sectors, with private:public cost ratios
*Values are median (IQR). ACT Artemisinin-based Combination Therapy